MedTrace Logo

Dopamine and Norepinephrine in Shock Patients

NCT00314704 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1679

Last updated 2010-02-01

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of dopamine and norepinephrine, two commonly used vasopressor agents, in the treatment of shock.

Conditions

  • Shock

Interventions

DRUG

dopamine versus norepinephrine

Sponsors & Collaborators

  • Sepsis Occurrence in Acutely Ill Patients

    lead OTHER

Principal Investigators

  • Daniel De Backer, MD, PhD · SOAP investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Austria
  • Belgium
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00314704 on ClinicalTrials.gov